EUVIMEDEUVIMED entdecken
Crossref

L26/O-180 A simple assay to spare azoospermic men from an unnecessary testicular biopsy

L. Ng, S. Cheung, Z. Rosenwaks, G. Palerm

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von L. Ng und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can a non-invasive assay performed on ejaculated seminal plasma of men with idiopathic non-obstructive azoospermia (iNOA) predict residual spermatogenesis at subsequent testicular biopsy? Summary answer We identified a simple semen analysis test to predict residual spermatogenesis and presence of spermatozoa in men undergoing microdissection testicular sperm extraction (m-TESE). What is known already In iNOA men, the only chance to father their own biological children is by retrieving spermatozoa through testicular biopsy. In this cohort, the likelihood of finding spermatozoa in the seminiferous tubules is at best 60%. Although several predictive laboratory and clinical parameters have been reported in the literature, no specific assay has been able to reliably predict residual spermatogenesis. Here we propose a simple assay performed on the ejaculates of iNOA men to predict the presence of spermatozoa at subsequent testicular biopsy. Study design, size, duration Over the past six years, 53 consenting men with repeated failed extensive semen analysis underwent RNAseq and DNAseq of their ejaculated samples prior to undergoing m-TESE extraction. Men with Klinefelter’s syndrome, Y-microdeletion, or a history of radiotherapy were excluded; of these 42 iNOA men underwent the genetic studies. Participants/materials, setting, methods RNA and DNA from those 42 men and selected fertile controls were isolated from seminal plasma using a commercially available kit and sequenced by Illumina HiSeq3000/4000 platform in efforts to assess genetic profile and detect mutations. An absolute log2fold change of > 1 and a P-value of < 0.0005 were considered statistically significant. Some of the samples were additionally fixed onto slides for an expedited RNA FISH analysis. Main results and the role of chance Transcriptomic analysis of 42 ejaculates from iNOA men were assessed for a total of 44,221 genes. A total of 3,505 imbalanced genes were identified, of which 8 were common to all participants, and 2 genes were consistently overexpressed in 19 men while underexpressed in 23. Of these two specific genes TPTE2, a testis-specific gene that regulates spermatogenesis, and NEU1, a gene involved in acrosome development and fertilization, were identified. Utilizing these results as a guide, the 42 men were divided into two cohorts based on whether they exhibited overexpression (OE) or underexpression (UE) of these two genes. DNAseq confirmed that the OE group exhibited unaffected TPTE2 gene along with synonymous mutation in NEU1, while the UE showed severe frameshift mutations of both genes. All 42 men eventually underwent m-TESE and interestingly, spermatozoa were identified in all 19 men the OE group, while the 23 men in the UE group failed to yield spermatozoa. In a preliminary test with an expedited RNA FISH assay also performed on ejaculates, the 3 patients who exhibited OE (immunofluorescence) of the NEU1 gene yielded spermatozoa at m-TESE, while the 2 patients who exhibited UE (immunofluorescence) failed m-TESE. Limitations, reasons for caution Although our study identified two promising genes that appear to predict m-TESE outcome, it is unclear whether these genes directly affect spermatogenesis or are simply associated with azoospermia. The results obtained from the expedited immunofluorescence assay by RNA FISH are still preliminary and need confirmation in a larger sample size. Wider implications of the findings The availability of a non-invasive assay on the ejaculates of azoospermic men is capable of predicting a successful sperm retrieval at testicular biopsy. This assay can guide physicians to better manage patient expectations and eventually spare infertile men from a costly and unnecessary surgical procedure. Trial registration number No

Zitieren

APA

Ng, L., Cheung, S., Rosenwaks, Z., & Palerm, G. (2026). L26/O-180 A simple assay to spare azoospermic men from an unnecessary testicular biopsy. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.178

Vancouver

Ng L, Cheung S, Rosenwaks Z, Palerm G. L26/O-180 A simple assay to spare azoospermic men from an unnecessary testicular biopsy. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.178

BibTeX
@article{Ng2026,
  author = {Ng, L. and Cheung, S. and Rosenwaks, Z. and Palerm, G.},
  title = {L26/O-180 A simple assay to spare azoospermic men from an unnecessary testicular biopsy},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.178}
}
Kostenlos starten →